Bertin Bioreagent has always made a great deal of effort into its Cancer Research tools offer…
As respond to your ever-varying needs is our top priority, we established clever partnerships and are now glad to present you an new expanded Cancer range...
What are you looking for?
Assets:
> Assay 45 samples in duplicate
> Plate-based fluorometric measurement
> Low background, high sensitivity
Assets:
> Multiplexed
> Ready-to-use HTS friendly (easy to work on 96 wells station) for screening
> Economical & time saver
> Exclusive technology
Assets:
> Measures major oxidative damage markers
> Detects all three oxidized guanine species
> Captures a more complete set of biologically relevant products of oxidative damage
Assets:
> Quantifies 5-methyl-2’-deoxy cytidine in urine, plasma, cell lysates, and tissue culture supernatants
> Measures 5-methyl-2’-deoxy cytidine levels down to 3 ng/ml
Assets:
> Measures products of oxidative DNA/RNA damage
> Quantifies both 8-OH-2dG & 8-OHG
> Correlates with LC-MS
RTK B (HER1, HER2...) (human) MS2Plex® assay kit - Cat No: T05048 > Order RTK B
RTK C (FAK1, FAK2...) (human) MS2Plex® assay kit - Cat No: T05049 > Order RTK C
Assets:
> M/S - 21 cancer markers in one run
> Highly specific of the targeted protein
> Ready-to-use assay kit
Human PPARγ Reporter Assay System - Cat No: IB00101-32 > Order PPARy Human
Rodent PPARγ Reporter Assay System - Cat No: MR00101-32 > Order PPARy Rodent
Assets:
> Cell-based, all-inclusive, robust, & ready-to-use kits
> Fast, accurate, and easy to analyse results
> Helpful for extrapolating data prior to animal & clinical trials
Assets:
> Measures products of oxidative DNA/RNA damage
> Quantifies both 8-OH-2dG & 8-OHG
> Correlates with LC-MS
Anti-cancer Library (10mM solution per well) - Cat No: L2100 > Order Library
Assets:
> Unique collection of 933 compounds for use in cancer-related research and for high-throughput screening and high-content screening
Assets:
> Selective estrogen receptor (ER) modulator
> ER antagonist in breast tisse & breast cells
> Effective in treating arly breast cancer to prevent tumor growth
To be active, Tamoxifen requires transformation > See also our Tamoxifen metabolites reagents